During the last two years these investigators have learned several key properties of the cyclin-dependent kinases that have helped understand how these kinases recognize their substrates and how they might develop technical approaches to allow rapid identification of substrates for the cell-cycle-regulating kinases. The investigators have developed two techniques for screening of new substrates of the CDK2 kinases, enzymes that control the last steps of G1 and the early steps of DNA synthesis. They have identified six new potential cyclin E/CDK2 substrates to date. Two of the new substrates have been characterized in sufficient detail to believe that they are in vivo substrates. In this application, it is proposed to continue examination of how cyclin/CDK complexes recognize their substrates, to expand the validation of the substrate screening methods, to extend these screens to look for substrates for a limited set of other CDK family members, and to study the function of the new substrates through these screens.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA074498-06
Application #
2397444
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Project Start
1992-09-30
Project End
2002-08-31
Budget Start
1997-09-30
Budget End
1998-08-31
Support Year
6
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Lee, S B; Kim, S H; Bell, D W et al. (2001) Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome. Cancer Res 61:8062-7